Forty-eight hours, then call a surgeon
What a new pleural standard made measurable

For most of my career, the decision of when to call the thoracic surgeon about a pleural problem was a matter of local habit rather than a number. A new national standard has quietly turned three of those decisions into a clock — and it is worth saying, from the receiving end, why a surgeon welcomes that.

Why pleural disease needed a standard, not a discovery

Pleural disease — fluid, infection, or air collecting where it should not — is one of the commonest ways a chest problem turns urgent, and for years it occupied an odd institutional gap: common enough to be everywhere, specialised enough that no single team quite owned it. A great deal of it was managed out of hours, by whoever was free, with a chest drain and good intentions. The science was never the missing piece; the British Thoracic Society's 2023 guideline already set out what good care looked like. What was missing was any way to tell whether a given hospital was actually delivering it — measurable markers rather than further recommendations. That is the gap this new standard sets out to close.

What the standard actually measures

Published in May 2026 and co-chaired by Mark Roberts and Najib Rahman, the standard takes the 2023 guideline and makes it auditable: sixteen quality statements, each expressed as a proportion a service can hold itself to, modelled on the method NICE uses for its own standards. They are explicitly not new targets handed down from above; they are markers a unit can use to ask whether its own pleural care is good enough. They span the whole pathway — how quickly fluid is sampled and a diagnosis reached, how malignant effusions are controlled, how infection is escalated, how a pneumothorax is treated. Read end to end, the document's quiet achievement is not any single statement but that it makes the interfaces measurable: the handovers between teams, which is exactly where pleural care has always been most likely to fall through.

The diagnosis you want to make once

Two of the statements are really about getting the diagnosis right the first time. Where pleural malignancy is suspected, tissue should be sampled within five working days of referral, and the molecular results that increasingly determine treatment should return within ten. And where fluid analysis is inconclusive, the standard says to proceed to a biopsy rather than repeat a low-yield tap — because repeating a test that has already failed mostly buys delay, and because a sample too small for molecular testing is, in 2026, not really a diagnosis. It is the same discipline I have argued for in the investigation of a screen-detected nodule: the first test should be the one most likely to answer the question, not the easiest one to request.

Three statements put a clock on the surgeon

The sharpest change lies in the three statements that govern when a surgeon enters the picture. In pleural infection, once medical treatment has failed — and the standard defines failure precisely, as a drain that has stopped draining while both a residual collection and the inflammation persist — the patient should have intrapleural enzyme therapy, a thoracic surgical opinion, or both, within forty-eight hours. The enzyme therapy is the clot-dissolving combination the MIST trials were built to test; I co-authored the MIST-3 feasibility study and co-lead the Guy's site of its successor, MIST-4. In prolonged air leak — a pneumothorax still leaking after three to five days on a drain — the standard asks for a discussion with thoracic surgeons within twenty-four hours, and is unusually plain in its reasoning: surgery is the best option for sealing the leak and reducing the chance of recurrence, while the alternatives, endobronchial valves among them, are less effective and are reserved for patients unfit to operate. And after a second pneumothorax on the same side, or a first on the other, it says the patient should be considered for an operation to prevent the next. None of these mandates surgery. Each mandates that the conversation happen, on a clock, and be written down.

When the clock should start

What I would add, from the receiving end, is that the timing may matter even more than the standard makes explicit. Guy's and St Thomas' is the regional thoracic surgical centre for much of south-east London, Kent and Sussex — a catchment of around five million people — which means most of these patients reach me by transfer, not from the ward next door. By the time medical failure is formally declared at forty-eight hours, a slower clock has usually been running for days: the time taken to recognise the problem, refer it, have it accepted, arrange the transfer and reassess on arrival. The standard's forty-eight hours are counted from the moment failure is named. The harder question, and the one a regional service feels most keenly, is whether the surgeon should sometimes be in the conversation before that — early enough that the operation, when it comes, is still the smaller one. Making the handover measurable is the first step. Measuring it from the right moment is the next.

← Back to the Journal